CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Código QR

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Sixteen female patients with diabetes-associated osteoarthritis (DAOA) participated in an openlabel, randomized, cross-over study. The mean patients’ age was 65.5 (±5.4) years, the patients were obese (mean body mass index, 35.8±5.7 kg/m2 ). They suffered from durable osteoarthritis (14.5±7.6 years)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	V. S. Shirinsky, E. V. Kazygasheva, N. Yu. Kalynovskaya, I. V. Shirinsky
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2017
Materias:	osteoarthritis comorbidity type 2 diabetes peroxisome proliferator-activated receptors α lipids cytokines inflammation Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/9100c7cc1e40494ca866e45e63e639ba
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
por: E. V. Kazygasheva, et al.
Publicado: (2016)

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2015)

Nutrición molecular, papel del sistema PPAR en el metabolismo lipídico y su importancia en obesidad y diabetes mellitus: regulation of lipid metabolism by peroxisome proliferator activated receptors (PPAR). Their relatioship to obesity and diabetes mellitus
por: Uauy D,Ricardo, et al.
Publicado: (2000)

PPAR research

Pleiotropic effects of PPAR-α – from benchside to bedside
por: I. V. Shirinsky, et al.
Publicado: (2021)

(+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway
por: Yiyuan Xi, et al.
Publicado: (2021)

Clinical and immunological features of metabolic phenotype of osteoarthritis
por: V. S. Shirinsky, et al.
Publicado: (2020)

PPARα Modulation-Based Therapy in Central Nervous System Diseases
por: Deokho Lee, et al.
Publicado: (2021)

INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
por: V. S. Shirinsky, et al.
Publicado: (2019)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
por: Ayza MA, et al.
Publicado: (2020)

Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study
por: V. S. Shirinsky, et al.
Publicado: (2020)

Development of comorbidity-adapted exercise protocols for patients with knee osteoarthritis
por: de Rooij M, et al.
Publicado: (2014)

Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis
por: Wei S, et al.
Publicado: (2020)

CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: I. V. Shirinsky, et al.
Publicado: (2016)

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
por: Shadi Esmaeili, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
por: Giuliana Muzio, et al.
Publicado: (2021)

COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
por: I. V. Shirinsky, et al.
Publicado: (2015)

Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
por: Wan R, et al.
Publicado: (2019)

Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia
por: Imamura M, et al.
Publicado: (2014)

Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages
por: Ling Liang, et al.
Publicado: (2021)

Synovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients
por: Richard T. Meehan, et al.
Publicado: (2021)

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY
por: I. V. Shirinsky, et al.
Publicado: (2019)

Modified frailty index as a predictor of the long-term functional result in patients undergoing primary total hip arthroplasty
por: Łukasz Pulik, et al.
Publicado: (2020)

Securidaca inappendiculata-Derived Xanthones Protected Joints from Degradation in Male Rats with Collagen-Induced Arthritis by Regulating PPAR-γ Signaling
por: Zuo J, et al.
Publicado: (2021)

The PPARα Agonist Fenofibrate Prevents Formation of Protein Aggregates (Mallory-Denk bodies) in a Murine Model of Steatohepatitis-like Hepatotoxicity
por: Aniket Nikam, et al.
Publicado: (2018)

Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples
por: Brigitte Sibille, et al.
Publicado: (2021)

PROINFLAMMATORY CYTOKINE LEVELS AND INDEXES OF ENDOTHELIAL FUNCTION IN PATIENTS WITH OSTEOARTHRITIS IS DEPENDENT ON THE PAIN INTENSITY
por: E. Yu. Aleksenko, et al.
Publicado: (2017)

EFFECT OF DEXAMETHASONE ON INTERFERON-α-INDUCED DIFFERENTIATION OF MONOCYTES TO DENDRITIC CELLS
por: Yu. D. Kurochkina, et al.
Publicado: (2016)

Peroxisomal Membrane Contact Sites in Yeasts
por: Amit S. Joshi
Publicado: (2021)

Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial
por: C. Benini, et al.
Publicado: (2021)

Involvement of PAR2 in platelet‐derived growth factor receptor‐α‐positive cell proliferation in the colon of diabetic mice
por: Yu‐Jia Li, et al.
Publicado: (2021)

Scaffold-based pan-agonist design for the PPARα, PPARβ and PPARγ receptors.
por: Li-Song Zhang, et al.
Publicado: (2012)

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis
por: Migliore A, et al.
Publicado: (2019)

Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Chen Lin, et al.
Publicado: (2021)

Analytical Study of Clinicopathological Data of Saudi Patients with Osteoarthritis Subjected to Total Knee Arthroplasty
por: Abd-El-Aziz,Gamal S, et al.
Publicado: (2019)

RASA4 inhibits the HIFα signalling pathway to suppress proliferation of cervical cancer cells
por: Junying Chen, et al.
Publicado: (2021)

DIAGNOSTIC AND PREDICTIVE VALUE OF TNF Α, IL-8 AND IL-6 ASSAYS IN THE PATIENTS WITH MYCOPLASMA-ASSOCIATED PNEUMONIAS
por: T. I. Dolgikh, et al.
Publicado: (2014)

Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway
por: Hou CH, et al.
Publicado: (2021)

THE PRODUCTION OF PRO- AND ANTIINFLAMMATORY CYTOKINES BY SYNOVIAL FIBROBLASTS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN VITRO WHEN USING DNA METHYLATION MODULATORS - INVESTIGATIVE STUDY
por: M. A. Shnayder, et al.
Publicado: (2019)

The Role of Vitamin D in Early Knee Osteoarthritis and Its Relationship with Their Physical and Psychological Status
por: Ana Alabajos-Cea, et al.
Publicado: (2021)